Tiziana Life Sciences Statistics
Total Valuation
TLSA has a market cap or net worth of $197.18 million. The enterprise value is $191.71 million.
Important Dates
The last earnings date was Friday, May 1, 2026, after market close.
| Earnings Date | May 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TLSA has 127.62 million shares outstanding. The number of shares has increased by 6.81% in one year.
| Current Share Class | 127.62M |
| Shares Outstanding | 127.62M |
| Shares Change (YoY) | +6.81% |
| Shares Change (QoQ) | +5.97% |
| Owned by Insiders (%) | 47.51% |
| Owned by Institutions (%) | 2.37% |
| Float | 66.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3,755.09 |
| P/TBV Ratio | 3,755.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.76, with a Debt / Equity ratio of 8.77.
| Current Ratio | 0.76 |
| Quick Ratio | 0.72 |
| Debt / Equity | 8.77 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -924.32% and return on invested capital (ROIC) is -580.55%.
| Return on Equity (ROE) | -924.32% |
| Return on Assets (ROA) | -115.96% |
| Return on Invested Capital (ROIC) | -580.55% |
| Return on Capital Employed (ROCE) | -7,388.81% |
| Weighted Average Cost of Capital (WACC) | 6.45% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.05M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.59% in the last 52 weeks. The beta is 0.40, so TLSA's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -1.59% |
| 50-Day Moving Average | 1.31 |
| 200-Day Moving Average | 1.65 |
| Relative Strength Index (RSI) | 66.43 |
| Average Volume (20 Days) | 163,954 |
Short Selling Information
The latest short interest is 1.29 million, so 1.51% of the outstanding shares have been sold short.
| Short Interest | 1.29M |
| Short Previous Month | 1.46M |
| Short % of Shares Out | 1.51% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.36 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -21.13M |
| Pretax Income | -18.43M |
| Net Income | -18.43M |
| EBITDA | -21.12M |
| EBIT | -21.13M |
| Earnings Per Share (EPS) | -$0.16 |
Full Income StatementBalance Sheet
The company has $4.01 million in cash and $456,000 in debt, with a net cash position of $3.55 million or $0.03 per share.
| Cash & Cash Equivalents | 4.01M |
| Total Debt | 456,000 |
| Net Cash | 3.55M |
| Net Cash Per Share | $0.03 |
| Equity (Book Value) | 52,000 |
| Book Value Per Share | 0.00 |
| Working Capital | -2.66M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$12.85 million and capital expenditures -$21,000, giving a free cash flow of -$12.87 million.
| Operating Cash Flow | -12.85M |
| Capital Expenditures | -21,000 |
| Depreciation & Amortization | 12,000 |
| Net Borrowing | -196,000 |
| Free Cash Flow | -12.87M |
| FCF Per Share | -$0.10 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
